SeizEAR Safety Study for Epilepsy Detection

This study is testing a new in-ear device called SeizEAR to see if it can safely and effectively detect seizures. The SeizEAR device fits in your ear canal and measures electrical signals. Researchers want to see how well it works compared to the standard scalp-based EEG (electroencephalogram), which measures brain activity. Initially, the study will enroll 5 healthy volunteers aged 18 to 70 who have no history of seizures. If successful, 10 participants with seizures or suspected seizures will then test the device. The main goals are to measure how accurately SeizEAR detects seizures (sensitivity, F1 score, and positive predictive value) over 16 weeks. The study status is currently unclear.

Study design
This is an interventional study planning to enroll 15 participants. It will first test 5 healthy individuals, then 10 participants with seizures or suspected seizures.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The main measurements for this study will be taken at week 16.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07088835

SeizEAR Safety Study

Recruiting
NAAges 18–70InterventionalDevice feasibility
Icahn School of Medicine at Mount Sinai
~15 participants
Updated 2025-12-23 on ClinicalTrials.gov
What's tested:SeizEAR

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Sensitivity
Measured over at week 16
+4 more outcomes measured
Epilepsy
1 sites across 1 states
New York1
  • Ho Wing (Andy) Chan, MD · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age: \> 18 and \<70
No History of Seizures or seizure-like activity based on self-report
Normal parameters for vitals, afebrile, blood pressure.
Able to read and write English
Capable of providing informed consent
Age \> 18 and \< 70
Individuals scheduled for clinical EEG for seizures or suspected temporal lobe seizures documented by a neurologist
Stable Health Conditions based upon the principal investigator's opinion
Normal parameters for vitals, afebrile, blood pressure
Able to read and write English
Capable of providing informed consent.

Exclusion

History of seizures or seizure-like activity based on self-assessment
Any major health conditions based upon self-report
Concurrent participation in another investigational protocol.
A history of skin sensitivity, or rash on the head, neck or ears.
A history of silver allergy.
Treatment for an ear infection in the previous four-week period
Medications that would be contraindicated to participate in the study that would interfere with the EEG Testing
Any major issues with the skull or ear that would interfere with the EEG testing.
A history of skin sensitivity, or rash on the head, neck or ears
A history of silver allergy.
Treatment for an ear infection in the previous four-week period.
Concurrent participation in another investigational protocol
Any psychiatric disorder (i.e. uncontrolled depression, mood disorders, cognitive impairment, schizophrenia), that complicate measurement of changes associated with the EEG testing.
  • Sensitivityat week 16

    The sensitivity of ear-EEG will be measured by sensitivity the percentage of ear-EEG predictions that overlap with conventional EEG annotations for at least 1 second per 24 hours accordingly. The ear-EEG annotations will be considered as predictions and the conventional EEG annotations as the truth. Any prediction was deemed true if they overlap at least 1 second with the truth. All seizure annotations were either true positive (TP), false positive (FP), or false negative (FN).

  • F1 scoreat week 16

    The Device F1 Score is a metric used to evaluate the performance of the ear-EEG device in detecting seizures. It is the harmonic mean of precision and recall, providing a balance between these two metrics. Precision is the proportion of true positive (TP) predictions out of all positive predictions (TP + FP), while recall (or sensitivity) is the proportion of true positive (TP) predictions out of all actual seizure events. The F1 Score ranges from 0 to 1, with higher scores indicating better performance in accurately detecting seizures. The performance of ear-EEG will be measured by the device F1 score per 24 hours accordingly.

  • Positive predictive value (PPV)at week 16

    The Device Positive Predictive Value (PPV) is calculated by dividing the number of true positives (TP) by the total number of positive test results (TP + FP), where FP represents false positives. PPV measures the accuracy of the ear-EEG device in predicting seizures, indicating the likelihood that a positive prediction made by the device is a true seizure event. The PPV ranges from 0 to 1, with higher values indicating better accuracy in predicting seizures. The performance of ear-EEG will be measured by the positive predictive value (PPV) per 24 hours accordingly.

  • False detection rateat week 16

    The Device False Detection Rate is a metric used to evaluate the performance of the ear-EEG device in terms of false positives. It is calculated by dividing the number of false positives (FP) by the total number of test results (TP + FP + FN), where TP represents true positives and FN represents false negatives. The false detection rate is typically expressed as the number of false positive predictions per 24 hours. Lower values indicate better performance, with fewer false alarms generated by the device.. The performance of ear-EEG will be measured by false detection rate per 24 hours accordingly.

  • Comfort Rating Scaleat week 16

    The Comfort Rating Scale is a 6-item questionnaire that asks participants about their comfort with the device. Responses are on a 5-point Likert scale ranging from 0 (not comfortable at all) to 5 (completely comfortable). The items assessed include tightness, weight, security, softness, overall comfort, and overall fit of the device in the ear. Total scores range from 0 to 30, with higher scores indicating greater comfort.